Eocene (EOCN) vs Ernexa Therapeutics (ERNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ernexa Therapeutics is the larger company by market cap ($3.9 million vs $3.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | EOCN | ERNA |
|---|---|---|
| Share price | $3.46 | $2.39 |
| Market cap | $3.69M | $3.90M |
| 1-day change | +2.91% | +6.94% |
| EPS (TTM) | $-15.21 | $-13.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.88 | $71.50 |
| 52-week low | $3.12 | $2.15 |
| Distance from 52-week high | -73.15% | -96.66% |
| Average volume | 60.46K | 462.76K |
| Shares outstanding | 1.07M | 1.63M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
EOCN vs ERNA FAQ
Which is bigger, Eocene or Ernexa Therapeutics?
Ernexa Therapeutics (ERNA) is larger, with a market capitalization of $3.90M compared with $3.69M for Eocene (EOCN).
Are Eocene and Ernexa Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.